BRUSSELS (dpa-AFX) - Swiss stocks were flat on Tuesday, underperforming gains in other European markets amid positive U.S. economic data.
The Conference Board's U.S. Consumer Confidence Index rose to 90.9, above the prior month's showing of 86.4 -- the best reading since 2007.
The Swiss Market Index rose 0.02 percent to 8,532.11.
UBS booked a 254 million euro ($341.25 million) charge in the second quarter mainly to settle claims it helped wealthy Germans to dodge taxes. The stock slipped 2 percent.
Roche said on Tuesday that European regulators approved its drug Gazyvaro for patients with chronic lymphocytic leukaemia. Shares slipped 0.2 percent.
Temenos posted a modest second-quarter rise in sales. Shares rose 1.2 percent.
Copyright RTT News/dpa-AFX